Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data with Vidutolimod at the 2021 American Association for Cancer (AACR) Annual Meeting
Go back to Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data with Vidutolimod at the 2021 American Association for Cancer (AACR) Annual Meeting| Cold Metal Products, Inc. (NASDAQ: CMPI) | Delayed: 10.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.50 | 52 Week High | $0.00 | |||
| Open | $10.50 | 52 Week Low | $0.00 | |||
| Day High | $10.50 | P/E | N/A | |||
| Day Low | $10.50 | EPS | $0.00 | |||
| Volume | 86,903 | |||||
